NCT06509984View on ClinicalTrials.gov

A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 6, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

April 1, 2026

Conditions
Epidermolysis Bullosa SimplexGenodermatosis
Interventions
DRUG

Apremilast treatment

treatment of apremilast

Trial Locations (4)

31059

NOT_YET_RECRUITING

chu de Toulouse, Toulouse

75015

NOT_YET_RECRUITING

APHP Necker-Enfants-Malades, Paris

75018

NOT_YET_RECRUITING

APHP Hôpital Saint-Louis, Paris

06000

RECRUITING

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER